Our hosting provider will be undergoing maintenance on Tuesday, August 30 between 8am and 5pm PDT. SciCrunch services may be offline during the maintenance.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.

The authors report the long-term course of two siblings with L-dopa responsive dystonia (DRD) associated with a compound heterozygous mutation in the tyrosine hydroxylase (TH) gene. Both siblings manifested with lower-limb onset generalized DRD and had a sustained response to low-dose L-dopa therapy for over 35 years. Although the l-dopa therapy was delayed up to 20 years after disease onset, there were no cognitive or neurologic sequelae of the long-term catecholamine deficit.

Pubmed ID: 15505183

Authors

  • Schiller A
  • Wevers RA
  • Steenbergen GC
  • Blau N
  • Jung HH

Journal

Neurology

Publication Data

October 26, 2004

Associated Grants

None

Mesh Terms

  • Adult
  • Age of Onset
  • Brain
  • Brain Chemistry
  • Catecholamines
  • DNA Mutational Analysis
  • Disease Progression
  • Dopamine Agents
  • Dystonia
  • Heterozygote
  • Humans
  • Levodopa
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Panic Disorder
  • Point Mutation
  • Siblings
  • Time
  • Tyrosine 3-Monooxygenase